In an AD-like murine model, topical delgocitinib was implicated to suppress IL-31-promoted nerve elongation in vivo and morphological changes of peripheral nerves from the dorsal root ganglion in vitro (75). The gene discussed is IL31; the disease is Alzheimer disease.